Results · Apr-Jun 2026 · filed 14 Aug 2026
Dolphin Medical Services Q1 FY27 results
Sales grew 22% to ₹0.21 crore from ₹0.17 crore in Apr-Jun 2025.
Operating profit fell 8% to ₹0.03 crore, an operating margin of 15.5% (down 5.0 points from a year ago).
Net profit fell 43% to ₹0.02 crore from ₹0.03 crore in Apr-Jun 2025.
Against Jan-Mar 2026: sales +7%, net profit +151%.
Apr-Jun 2026 vs a year ago
| ₹ crore | Apr-Jun 2026 | Apr-Jun 2025 | Change |
|---|---|---|---|
| Sales | 0.2 | 0.2 | +22% |
| Operating profit (EBITDA) | 0.0 | 0.0 | −8% |
| Operating margin | 15.5% | 20.5% | −5.0 pts |
| Net profit | 0.0 | 0.0 | −43% |
Standalone figures. Margins & ratios change in percentage points (pts).
The last 7 quarters
Filings that week
- 14 Aug 2026Results: Unaudited Financial Results For The Quarter Ended June 30, 2026
- 14 Aug 2026Board Meeting Outcome for Unaudited Financial Results For The Quarter Ended June 30, 2026
From the company's results filed on BSE (Standalone). Business numbers only. Education & analysis, not investment advice or a recommendation.